(Q74254242)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

G Page

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Peeters

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J M Maloteaux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Hermans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

75-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Correlation between (3H)dopamine specific uptake and (3H)GBR 12783 specific binding during the maturation of rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Studies on the mechanism of action of amantadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Amantadine and catecholamine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Ketamine stereoselectively inhibits rat dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

MK-801 blocks monoamine transporters expressed in HEK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

A simplification of the protein assay method of Lowry et al. which is more generally applicable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Amantadine modulates phencyclidine binding site sensitivity in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Amantadine in the Treatment of Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900573-2

10.1016/S0014-2999(00)00573-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969146%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference